Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds
ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer
Half Of Women Complete Full Hormone Therapy Regimen
Surveillance Colonoscopy Cost-Effective For High-Risk
Surveillance Treatment Option For Low-Risk Prostate Cancer
Toxicity, Non-Cancer Deaths Increase With Combo Therapy
Time Spent Sitting Associated With Total Mortality, Study Finds
Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds
NCI-Approved Clinical Trials
Trending Stories
- As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research - As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer
- Trump 2016: A look back at the 45th president’s impact on oncology
- Cedars-Sinai spearheads first national certification program for COE staff at cancer centers
- Menin inhibitors emerge as new treatment for advanced AML
- Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began